⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SMMT News
Summit Therapeutics Inc. Common Stock
Form 8-K
sec.gov
SMMT
Form 8-K
sec.gov
SMMT
Form 8-K
sec.gov
SMMT
Form 8-K
sec.gov
SMMT
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
businesswire.com
SMMT
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
businesswire.com
SMMT
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic
prnewswire.com
IPHA
GTBP
GSK
SMMT
IDYA
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
globenewswire.com
GTBP
SMMT
IDYA
RADX
Summit Therapeutics Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
SMMT
Form 8-K
sec.gov
SMMT